Drreddys Laboratories | RDY - Ebitda


Drreddys Laboratories reported INR18.79B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
ANI Pharmaceuticals USD 83.3M 11.7M Sep/2026
Aurora Cannabis CAD 799K 2.9M Jun/2026
Bayer EUR 1.62B 529M Sep/2026
Canopy Growth CAD 8M 145M Jun/2026
Cipla INR 13.88B 154.2M Sep/2026
Corcept Therapeutics USD 115.75M 73.59M Sep/2026
Drreddys Laboratories INR 18.79B 10.16B Sep/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Novartis USD 8.62B 2.14B Sep/2026
Pacira USD 50.45M 1.78M Sep/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 89.44M 28.2M Sep/2026
Richter Gedeon HUF 90.34B 6.87B Jun/2026
Sun Pharmaceuticals INR 47.44B 3.26B Sep/2026
Supernus Pharmaceuticals USD 55.6M 24M Sep/2026
Teva Pharmaceutical Industries USD 1.5B 1.02B Sep/2026